The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

N/ACompletedNCT01612182

Inje University1,289 enrolled

Overview

The prevalence of ESBL Klebsiella pneumonia was higher in patient with renal replacement therapy.

Study Type

OBSERVATIONAL

Enrollment

1,289

Conditions

End-stage Renal Disease

Interventions

renal replacement therapyOTHER

renal replacement therapy : hemodialysis and/or CRRT(continuous renal replacement therapy )

Eligibility

Sex: ALLMin age: 18 YearsMax age: 79 Years

Medical Language ↔ Plain English

Inclusion Criteria: * The age of patient was between 18 yrs and 79 yrs. * The patient who showed Klebsiella pneumonia in 1st culture result of any site during hospitalization Exclusion Criteria: * The level of serum albumin was below 2.0 or over 5.0 * The level of AST or ALT was 2 times of normal level or the level of bilirubin was over 2.0 mg/dL during 1month. * The level of Body mass index was below 15 or over 30 * Pregnancy

Locations (1)

Inje University Seoul Paik hospital Instituional Board Review

Seoul, Je Dong 2ga, Jung Gu, South Korea

Outcomes

Primary Outcomes

The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy

The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011)

Time frame: During hospitalization

Secondary Outcomes

The prevalence of ESBL Klebsiella pneumonia in patient with pneumonia and renal replacement therapy

The prevalence of ESBL Klebsiella pneumoina in patient with pneumonia and renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011)

Time frame: during hospitalization

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.